Abstract
The majority of cancer patients receiving chemotherapy will consider taking complementary and alternative medicine (CAM) during their treatment. As biologically-active CAM may detrimentally interfere with chemotherapy treatment, cancer patients require evidence-based information on chemotherapy-CAM integration consequences. This study aimed to assess if the availability of a purpose-designed brochure within a cancer service aided doctors’ discussions with their patients on CAM use and helped patients understand the effects of CAM during their chemotherapy treatment. Cancer care doctors consulting in an adult day unit completed a structured post-intervention feedback survey form (n = 17), and cancer patients receiving chemotherapy treatment were provided the brochure and completed the local health service consumer testing feedback form (n = 30). All cancer care doctors perceived a need for the brochure and recommended the brochure to their patients. All doctors thought the brochure made it easier for them to discuss CAM with their patients, and 59 % believed that it saved them time during patient consultations. Ninety percent of cancer patients reported the brochure had enough information to answer their CAM questions, and all patients thought the information was easy to read and understand. An evidence-based CAM-with-chemotherapy patient brochure was perceived to have enabled cancer care doctors to discuss CAM with their patients and to have answered patients’ CAM questions.
Similar content being viewed by others
References
Lee RT, Barbo A, Lopez G, Melhem-Bertrandt A, Lin H, Olopade OI, Curlin FA (2014) National survey of US oncologists’ knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer. J Clin Oncol 32(36):4095–4101
Zollman C, Vickers A (1999) ABC of complementary medicine: what is complementary medicine? Br Med J 319(7211):693–696
Oh B, Butow P, Mullan B, Beale P, Pavlakis N, Rosenthal D, Clarke S (2010) The use and perceived benefits resulting from the use of complementary and alternative medicine by cancer patients in Australia. Asia Pac J Clin Oncol 6(4):342–349
Gianni AM, Piccart MJ (2000) Optimising chemotherapy dose density and dose intensity. New strategies to improve outcomes in adjuvant therapy for breast cancer. Eur J Cancer 36(Suppl 1):S1–S3
Smith PJ, Clavarino A, Long J, Steadman KJ (2014) CAM use by patients receiving curative intent chemotherapy. Eur J Oncol Pharm 8(2 suppl):42
McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12(6):454–462
King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, Truant T, Carlson LE (2015) Surveys of cancer patients and cancer health care providers regarding complementary therapy use, communication, and information needs. Integr Cancer Ther. doi:10.1177/1534735415589984
Lang T (n.d.) Developing patient education handouts. In. CA 95618: Tom Lang communications. http://tomlangcommunications.com/Expanded_Patient_Ed_Chapter.pdf. Accessed 18 Nov 2015
Smith PJ, Clavarino A, Long J, Steadman KJ (2014) Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks? Asia Pac J Clin Oncol 10(1):1–10
Diederich NJ, Goetz CG (2008) The placebo treatments in neurosciences: new insights from clinical and neuroimaging studies. Neurology 71(9):677–684
Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, Hickok JT, Morrow GR (2012) Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer 20(7):1479–1489
Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H (2007) Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 97(8):1028–1034
MacGregor G, Smith AJ, Thakker B, Kinsella J (2002) Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 78(920):366–367
Mehta A, Rangarajan S, Borate U (2012) A cautionary tale for probiotic use in hematopoietic SCT patients—Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplant. doi:10.1038/bmt.2012.153
Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC (2011) Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 117(8):1775–1782
Daenen LM, Cirkel GA, Houthuijzen JM et al (2015) Increased plasma levels of chemoresistance-inducing fatty acid 16:4(n-3) after consumption of fish and fish oil. JAMA Oncol. doi:10.1001/jamaoncol.2015.0388
Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB (2008) Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100(11):773–783
Smith PJ, Clavarino AM, Long JE, Steadman KJ (2015) Evaluation of a patient CAM-with-chemotherapy educational brochure. Evid Based Complement Alternat Med 2015:5. doi:10.1155/2015/408430
Tascilar M, de Jong FA, Verweij J, Mathijssen RH (2006) Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist 11(7):732–741
Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514
Balneaves LG, Weeks L, Seely D (2008) Patient decision-making about complementary and alternative medicine in cancer management: context and process. Curr Oncol 15(Suppl 2):s94–s100
Humpel N, Jones SC (2006) Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care (Engl) 15(4):362–368
Oh B, Butow P, Mullan B, Clarke S, Tattersall M, Boyer M, Beale P, Vardy J, Pavlakis N, Larke L (2010) Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. J Soc Integr Oncol 8(2):56–64
Bannerman B, Xu L, Jones M, Tsu C, Yu J, Hales P, Monbaliu J et al (2011) Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea. Cancer Chemother Pharmacol 68(5):1145–1154
Mercurio R, Eliott JA (2011) Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer. Support Care Cancer 19(1):67–80
Acknowledgments
The authors wish to thank the Sunshine Coast Hospital and Health Service for the publication design and printing assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was granted ethics exemption for publication by Human Research Ethics Committees at The Prince Charles Hospital and The University of Queensland.
Conflict of Interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOC 42 kb)
Supplementary Table 2
(DOC 46 kb)
ESM 1
CAM-with-chemotherapy patient educational brochure (PDF 1137 kb)
Rights and permissions
About this article
Cite this article
Smith, P.J., Clavarino, A.M., Long, J.E. et al. The Use of a Brochure to Enable CAM-with-Chemotherapy Patient Education. J Canc Educ 32, 814–819 (2017). https://doi.org/10.1007/s13187-016-1011-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-016-1011-8